nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiothixene—ALB—Vismodegib—skin cancer	0.176	0.225	CbGbCtD
Thiothixene—CYP1A2—Imiquimod—skin cancer	0.152	0.194	CbGbCtD
Thiothixene—ALB—Vemurafenib—skin cancer	0.139	0.178	CbGbCtD
Thiothixene—CYP1A2—Vemurafenib—skin cancer	0.0834	0.106	CbGbCtD
Thiothixene—CYP2D6—Vemurafenib—skin cancer	0.0687	0.0876	CbGbCtD
Thiothixene—CYP1A2—Dacarbazine—skin cancer	0.0639	0.0815	CbGbCtD
Thiothixene—ALB—Fluorouracil—skin cancer	0.0627	0.0799	CbGbCtD
Thiothixene—CYP1A2—Fluorouracil—skin cancer	0.0375	0.0478	CbGbCtD
Thiothixene—Edema cerebral—Temozolomide—skin cancer	0.0107	0.0588	CcSEcCtD
Thiothixene—Amenorrhoea—Vismodegib—skin cancer	0.00594	0.0328	CcSEcCtD
Thiothixene—Brain oedema—Temozolomide—skin cancer	0.00577	0.0318	CcSEcCtD
Thiothixene—HRH1—nose—skin cancer	0.00548	0.159	CbGeAlD
Thiothixene—Abnormal behaviour—Temozolomide—skin cancer	0.00443	0.0244	CcSEcCtD
Thiothixene—DRD1—nerve—skin cancer	0.00337	0.0979	CbGeAlD
Thiothixene—Parkinsonism—Fluorouracil—skin cancer	0.00334	0.0184	CcSEcCtD
Thiothixene—Photosensitivity—Vemurafenib—skin cancer	0.00267	0.0147	CcSEcCtD
Thiothixene—Muscle spasms—Vismodegib—skin cancer	0.0022	0.0121	CcSEcCtD
Thiothixene—Nasal congestion—Imiquimod—skin cancer	0.00219	0.0121	CcSEcCtD
Thiothixene—Extrapyramidal disorder—Temozolomide—skin cancer	0.00219	0.0121	CcSEcCtD
Thiothixene—HTR2A—hindlimb—skin cancer	0.00216	0.0627	CbGeAlD
Thiothixene—Dermatitis exfoliative—Imiquimod—skin cancer	0.00212	0.0117	CcSEcCtD
Thiothixene—Eosinophilia—Vemurafenib—skin cancer	0.002	0.011	CcSEcCtD
Thiothixene—DRD2—nerve—skin cancer	0.00199	0.0578	CbGeAlD
Thiothixene—Menstruation irregular—Docetaxel—skin cancer	0.00198	0.0109	CcSEcCtD
Thiothixene—Amenorrhoea—Temozolomide—skin cancer	0.00188	0.0103	CcSEcCtD
Thiothixene—HTR2A—appendage—skin cancer	0.00185	0.0538	CbGeAlD
Thiothixene—Photosensitivity reaction—Vemurafenib—skin cancer	0.00185	0.0102	CcSEcCtD
Thiothixene—Sweating increased—Imiquimod—skin cancer	0.00168	0.00927	CcSEcCtD
Thiothixene—Pancytopenia—Imiquimod—skin cancer	0.00164	0.00904	CcSEcCtD
Thiothixene—Decreased appetite—Vismodegib—skin cancer	0.00162	0.00893	CcSEcCtD
Thiothixene—Leukocytosis—Fluorouracil—skin cancer	0.00162	0.00891	CcSEcCtD
Thiothixene—Fatigue—Vismodegib—skin cancer	0.00161	0.00886	CcSEcCtD
Thiothixene—Oedema peripheral—Vemurafenib—skin cancer	0.0016	0.0088	CcSEcCtD
Thiothixene—Constipation—Vismodegib—skin cancer	0.00159	0.00878	CcSEcCtD
Thiothixene—Erectile dysfunction—Imiquimod—skin cancer	0.00159	0.00876	CcSEcCtD
Thiothixene—Photosensitivity reaction—Imiquimod—skin cancer	0.00158	0.00869	CcSEcCtD
Thiothixene—Dermatitis contact—Fluorouracil—skin cancer	0.0015	0.00828	CcSEcCtD
Thiothixene—Asthenia—Vismodegib—skin cancer	0.00134	0.00737	CcSEcCtD
Thiothixene—Pruritus—Vismodegib—skin cancer	0.00132	0.00727	CcSEcCtD
Thiothixene—Nasal congestion—Temozolomide—skin cancer	0.00131	0.00724	CcSEcCtD
Thiothixene—HTR2A—nerve—skin cancer	0.00131	0.0381	CbGeAlD
Thiothixene—Diarrhoea—Vismodegib—skin cancer	0.00128	0.00703	CcSEcCtD
Thiothixene—Dermatitis exfoliative—Temozolomide—skin cancer	0.00127	0.00699	CcSEcCtD
Thiothixene—Photosensitivity—Fluorouracil—skin cancer	0.00126	0.00692	CcSEcCtD
Thiothixene—Amenorrhoea—Docetaxel—skin cancer	0.00125	0.00688	CcSEcCtD
Thiothixene—Cough—Vemurafenib—skin cancer	0.00123	0.00678	CcSEcCtD
Thiothixene—Vomiting—Vismodegib—skin cancer	0.00118	0.00653	CcSEcCtD
Thiothixene—Rash—Vismodegib—skin cancer	0.00117	0.00648	CcSEcCtD
Thiothixene—Dermatitis—Vismodegib—skin cancer	0.00117	0.00647	CcSEcCtD
Thiothixene—Pancytopenia—Bleomycin—skin cancer	0.00116	0.00642	CcSEcCtD
Thiothixene—Anaphylactic shock—Vemurafenib—skin cancer	0.00115	0.00635	CcSEcCtD
Thiothixene—Dysphagia—Dactinomycin—skin cancer	0.00114	0.00631	CcSEcCtD
Thiothixene—HTR2A—endothelium—skin cancer	0.00112	0.0325	CbGeAlD
Thiothixene—Nausea—Vismodegib—skin cancer	0.00111	0.0061	CcSEcCtD
Thiothixene—Agitation—Imiquimod—skin cancer	0.00111	0.00609	CcSEcCtD
Thiothixene—Pancytopenia—Dactinomycin—skin cancer	0.00109	0.00599	CcSEcCtD
Thiothixene—Syncope—Imiquimod—skin cancer	0.00108	0.00595	CcSEcCtD
Thiothixene—Hypotension—Vemurafenib—skin cancer	0.00108	0.00593	CcSEcCtD
Thiothixene—HTR6—head—skin cancer	0.00107	0.0312	CbGeAlD
Thiothixene—Loss of consciousness—Imiquimod—skin cancer	0.00106	0.00583	CcSEcCtD
Thiothixene—Cough—Imiquimod—skin cancer	0.00105	0.00579	CcSEcCtD
Thiothixene—Cardiac arrest—Fluorouracil—skin cancer	0.00105	0.00578	CcSEcCtD
Thiothixene—Convulsion—Imiquimod—skin cancer	0.00104	0.00575	CcSEcCtD
Thiothixene—Dysphagia—Temozolomide—skin cancer	0.00103	0.0057	CcSEcCtD
Thiothixene—HTR2A—blood vessel—skin cancer	0.00103	0.0299	CbGeAlD
Thiothixene—Sweating increased—Temozolomide—skin cancer	0.00101	0.00556	CcSEcCtD
Thiothixene—Dry mouth—Imiquimod—skin cancer	0.001	0.00552	CcSEcCtD
Thiothixene—Decreased appetite—Vemurafenib—skin cancer	0.001	0.00552	CcSEcCtD
Thiothixene—Fatigue—Vemurafenib—skin cancer	0.000993	0.00547	CcSEcCtD
Thiothixene—Constipation—Vemurafenib—skin cancer	0.000984	0.00543	CcSEcCtD
Thiothixene—Pancytopenia—Temozolomide—skin cancer	0.000983	0.00542	CcSEcCtD
Thiothixene—Lightheadedness—Docetaxel—skin cancer	0.000981	0.00541	CcSEcCtD
Thiothixene—Shock—Imiquimod—skin cancer	0.000966	0.00532	CcSEcCtD
Thiothixene—Tachycardia—Imiquimod—skin cancer	0.000958	0.00528	CcSEcCtD
Thiothixene—Dysphagia—Fluorouracil—skin cancer	0.000953	0.00525	CcSEcCtD
Thiothixene—Erectile dysfunction—Temozolomide—skin cancer	0.000953	0.00525	CcSEcCtD
Thiothixene—CYP1A2—nipple—skin cancer	0.000953	0.0277	CbGeAlD
Thiothixene—Agranulocytosis—Dactinomycin—skin cancer	0.000952	0.00525	CcSEcCtD
Thiothixene—Hyperhidrosis—Imiquimod—skin cancer	0.000949	0.00523	CcSEcCtD
Thiothixene—Photosensitivity reaction—Temozolomide—skin cancer	0.000944	0.00521	CcSEcCtD
Thiothixene—Eosinophilia—Fluorouracil—skin cancer	0.000944	0.0052	CcSEcCtD
Thiothixene—Anorexia—Imiquimod—skin cancer	0.000936	0.00516	CcSEcCtD
Thiothixene—Hyperglycaemia—Temozolomide—skin cancer	0.000933	0.00514	CcSEcCtD
Thiothixene—Pancytopenia—Fluorouracil—skin cancer	0.000905	0.00499	CcSEcCtD
Thiothixene—HRH1—nipple—skin cancer	0.000892	0.0259	CbGeAlD
Thiothixene—Insomnia—Imiquimod—skin cancer	0.000888	0.00489	CcSEcCtD
Thiothixene—ADRA2A—nipple—skin cancer	0.000876	0.0255	CbGeAlD
Thiothixene—Dyspnoea—Imiquimod—skin cancer	0.000875	0.00482	CcSEcCtD
Thiothixene—Somnolence—Imiquimod—skin cancer	0.000873	0.00481	CcSEcCtD
Thiothixene—Photosensitivity reaction—Fluorouracil—skin cancer	0.00087	0.0048	CcSEcCtD
Thiothixene—Decreased appetite—Imiquimod—skin cancer	0.000853	0.0047	CcSEcCtD
Thiothixene—Hypersensitivity—Vemurafenib—skin cancer	0.000848	0.00468	CcSEcCtD
Thiothixene—Fatigue—Imiquimod—skin cancer	0.000846	0.00467	CcSEcCtD
Thiothixene—Asthenia—Vemurafenib—skin cancer	0.000826	0.00455	CcSEcCtD
Thiothixene—Oedema peripheral—Temozolomide—skin cancer	0.000816	0.0045	CcSEcCtD
Thiothixene—Pruritus—Vemurafenib—skin cancer	0.000815	0.00449	CcSEcCtD
Thiothixene—DRD1—head—skin cancer	0.000799	0.0232	CbGeAlD
Thiothixene—Agranulocytosis—Fluorouracil—skin cancer	0.000793	0.00437	CcSEcCtD
Thiothixene—Diarrhoea—Vemurafenib—skin cancer	0.000788	0.00434	CcSEcCtD
Thiothixene—Urticaria—Imiquimod—skin cancer	0.00078	0.0043	CcSEcCtD
Thiothixene—Leukopenia—Bleomycin—skin cancer	0.000765	0.00422	CcSEcCtD
Thiothixene—Dizziness—Vemurafenib—skin cancer	0.000761	0.0042	CcSEcCtD
Thiothixene—Cough—Bleomycin—skin cancer	0.000746	0.00411	CcSEcCtD
Thiothixene—HTR2C—female reproductive system—skin cancer	0.000743	0.0216	CbGeAlD
Thiothixene—HTR2A—neck—skin cancer	0.000737	0.0214	CbGeAlD
Thiothixene—Vomiting—Vemurafenib—skin cancer	0.000732	0.00403	CcSEcCtD
Thiothixene—Rash—Vemurafenib—skin cancer	0.000726	0.004	CcSEcCtD
Thiothixene—Dermatitis—Vemurafenib—skin cancer	0.000725	0.004	CcSEcCtD
Thiothixene—Hypersensitivity—Imiquimod—skin cancer	0.000723	0.00399	CcSEcCtD
Thiothixene—Leukopenia—Dactinomycin—skin cancer	0.000713	0.00393	CcSEcCtD
Thiothixene—Asthenia—Imiquimod—skin cancer	0.000704	0.00388	CcSEcCtD
Thiothixene—Anaphylactic shock—Bleomycin—skin cancer	0.000698	0.00384	CcSEcCtD
Thiothixene—Pruritus—Imiquimod—skin cancer	0.000695	0.00383	CcSEcCtD
Thiothixene—Dysphagia—Docetaxel—skin cancer	0.000688	0.00379	CcSEcCtD
Thiothixene—Nausea—Vemurafenib—skin cancer	0.000684	0.00377	CcSEcCtD
Thiothixene—Thrombocytopenia—Bleomycin—skin cancer	0.000683	0.00376	CcSEcCtD
Thiothixene—Vision blurred—Temozolomide—skin cancer	0.000679	0.00374	CcSEcCtD
Thiothixene—Diarrhoea—Imiquimod—skin cancer	0.000672	0.0037	CcSEcCtD
Thiothixene—Anorexia—Bleomycin—skin cancer	0.000665	0.00366	CcSEcCtD
Thiothixene—Agitation—Temozolomide—skin cancer	0.000663	0.00365	CcSEcCtD
Thiothixene—Pancytopenia—Docetaxel—skin cancer	0.000653	0.0036	CcSEcCtD
Thiothixene—Hypotension—Bleomycin—skin cancer	0.000652	0.00359	CcSEcCtD
Thiothixene—Dizziness—Imiquimod—skin cancer	0.000649	0.00358	CcSEcCtD
Thiothixene—Leukopenia—Temozolomide—skin cancer	0.000645	0.00356	CcSEcCtD
Thiothixene—Thrombocytopenia—Dactinomycin—skin cancer	0.000637	0.00351	CcSEcCtD
Thiothixene—HRH1—connective tissue—skin cancer	0.000633	0.0184	CbGeAlD
Thiothixene—SLC22A1—head—skin cancer	0.000632	0.0184	CbGeAlD
Thiothixene—Cough—Temozolomide—skin cancer	0.000629	0.00347	CcSEcCtD
Thiothixene—Vision blurred—Fluorouracil—skin cancer	0.000626	0.00345	CcSEcCtD
Thiothixene—Convulsion—Temozolomide—skin cancer	0.000625	0.00344	CcSEcCtD
Thiothixene—Vomiting—Imiquimod—skin cancer	0.000624	0.00344	CcSEcCtD
Thiothixene—Dyspnoea—Bleomycin—skin cancer	0.000622	0.00343	CcSEcCtD
Thiothixene—ADRA2A—connective tissue—skin cancer	0.000621	0.0181	CbGeAlD
Thiothixene—HTR2C—head—skin cancer	0.000621	0.018	CbGeAlD
Thiothixene—Anorexia—Dactinomycin—skin cancer	0.00062	0.00342	CcSEcCtD
Thiothixene—Rash—Imiquimod—skin cancer	0.000619	0.00341	CcSEcCtD
Thiothixene—Dermatitis—Imiquimod—skin cancer	0.000618	0.00341	CcSEcCtD
Thiothixene—Decreased appetite—Bleomycin—skin cancer	0.000606	0.00334	CcSEcCtD
Thiothixene—HRH1—epithelium—skin cancer	0.000601	0.0175	CbGeAlD
Thiothixene—Dry mouth—Temozolomide—skin cancer	0.0006	0.00331	CcSEcCtD
Thiothixene—Jaundice—Docetaxel—skin cancer	0.000598	0.0033	CcSEcCtD
Thiothixene—Leukopenia—Fluorouracil—skin cancer	0.000595	0.00328	CcSEcCtD
Thiothixene—Anaphylactic shock—Temozolomide—skin cancer	0.000588	0.00324	CcSEcCtD
Thiothixene—Nausea—Imiquimod—skin cancer	0.000583	0.00321	CcSEcCtD
Thiothixene—Thrombocytopenia—Temozolomide—skin cancer	0.000576	0.00318	CcSEcCtD
Thiothixene—Convulsion—Fluorouracil—skin cancer	0.000576	0.00317	CcSEcCtD
Thiothixene—Agranulocytosis—Docetaxel—skin cancer	0.000573	0.00316	CcSEcCtD
Thiothixene—Hyperhidrosis—Temozolomide—skin cancer	0.000569	0.00314	CcSEcCtD
Thiothixene—Decreased appetite—Dactinomycin—skin cancer	0.000565	0.00312	CcSEcCtD
Thiothixene—Fatigue—Dactinomycin—skin cancer	0.000561	0.00309	CcSEcCtD
Thiothixene—Anorexia—Temozolomide—skin cancer	0.000561	0.00309	CcSEcCtD
Thiothixene—Urticaria—Bleomycin—skin cancer	0.000554	0.00305	CcSEcCtD
Thiothixene—Oedema peripheral—Docetaxel—skin cancer	0.000543	0.00299	CcSEcCtD
Thiothixene—Anaphylactic shock—Fluorouracil—skin cancer	0.000542	0.00299	CcSEcCtD
Thiothixene—Insomnia—Temozolomide—skin cancer	0.000532	0.00293	CcSEcCtD
Thiothixene—Thrombocytopenia—Fluorouracil—skin cancer	0.000531	0.00293	CcSEcCtD
Thiothixene—Tachycardia—Fluorouracil—skin cancer	0.000529	0.00292	CcSEcCtD
Thiothixene—HTR2A—connective tissue—skin cancer	0.000528	0.0154	CbGeAlD
Thiothixene—Dyspnoea—Temozolomide—skin cancer	0.000525	0.00289	CcSEcCtD
Thiothixene—Somnolence—Temozolomide—skin cancer	0.000523	0.00288	CcSEcCtD
Thiothixene—HTR1A—head—skin cancer	0.000522	0.0152	CbGeAlD
Thiothixene—HRH1—mammalian vulva—skin cancer	0.000521	0.0151	CbGeAlD
Thiothixene—Anorexia—Fluorouracil—skin cancer	0.000517	0.00285	CcSEcCtD
Thiothixene—Hypersensitivity—Bleomycin—skin cancer	0.000514	0.00283	CcSEcCtD
Thiothixene—ADRA2A—mammalian vulva—skin cancer	0.000512	0.0149	CbGeAlD
Thiothixene—Decreased appetite—Temozolomide—skin cancer	0.000511	0.00282	CcSEcCtD
Thiothixene—Fatigue—Temozolomide—skin cancer	0.000507	0.0028	CcSEcCtD
Thiothixene—Hypotension—Fluorouracil—skin cancer	0.000507	0.00279	CcSEcCtD
Thiothixene—Constipation—Temozolomide—skin cancer	0.000503	0.00277	CcSEcCtD
Thiothixene—HTR2A—epithelium—skin cancer	0.000502	0.0146	CbGeAlD
Thiothixene—Asthenia—Bleomycin—skin cancer	0.0005	0.00276	CcSEcCtD
Thiothixene—Pruritus—Bleomycin—skin cancer	0.000493	0.00272	CcSEcCtD
Thiothixene—Insomnia—Fluorouracil—skin cancer	0.00049	0.0027	CcSEcCtD
Thiothixene—Dyspnoea—Fluorouracil—skin cancer	0.000483	0.00266	CcSEcCtD
Thiothixene—Somnolence—Fluorouracil—skin cancer	0.000482	0.00266	CcSEcCtD
Thiothixene—Hypersensitivity—Dactinomycin—skin cancer	0.000479	0.00264	CcSEcCtD
Thiothixene—DRD2—head—skin cancer	0.000472	0.0137	CbGeAlD
Thiothixene—Decreased appetite—Fluorouracil—skin cancer	0.000471	0.0026	CcSEcCtD
Thiothixene—Urticaria—Temozolomide—skin cancer	0.000467	0.00258	CcSEcCtD
Thiothixene—Asthenia—Dactinomycin—skin cancer	0.000467	0.00257	CcSEcCtD
Thiothixene—Muscle spasms—Docetaxel—skin cancer	0.000461	0.00254	CcSEcCtD
Thiothixene—HRH1—female reproductive system—skin cancer	0.000446	0.013	CbGeAlD
Thiothixene—Diarrhoea—Dactinomycin—skin cancer	0.000445	0.00245	CcSEcCtD
Thiothixene—Vomiting—Bleomycin—skin cancer	0.000443	0.00244	CcSEcCtD
Thiothixene—Rash—Bleomycin—skin cancer	0.00044	0.00242	CcSEcCtD
Thiothixene—Dermatitis—Bleomycin—skin cancer	0.000439	0.00242	CcSEcCtD
Thiothixene—ADRA2A—female reproductive system—skin cancer	0.000438	0.0127	CbGeAlD
Thiothixene—Hypersensitivity—Temozolomide—skin cancer	0.000433	0.00239	CcSEcCtD
Thiothixene—Urticaria—Fluorouracil—skin cancer	0.000431	0.00237	CcSEcCtD
Thiothixene—Syncope—Docetaxel—skin cancer	0.00043	0.00237	CcSEcCtD
Thiothixene—Leukopenia—Docetaxel—skin cancer	0.000429	0.00237	CcSEcCtD
Thiothixene—ALB—lymph node—skin cancer	0.000424	0.0123	CbGeAlD
Thiothixene—Asthenia—Temozolomide—skin cancer	0.000422	0.00233	CcSEcCtD
Thiothixene—Loss of consciousness—Docetaxel—skin cancer	0.000421	0.00232	CcSEcCtD
Thiothixene—Cough—Docetaxel—skin cancer	0.000418	0.00231	CcSEcCtD
Thiothixene—Pruritus—Temozolomide—skin cancer	0.000416	0.00229	CcSEcCtD
Thiothixene—Convulsion—Docetaxel—skin cancer	0.000415	0.00229	CcSEcCtD
Thiothixene—Nausea—Bleomycin—skin cancer	0.000414	0.00228	CcSEcCtD
Thiothixene—Vomiting—Dactinomycin—skin cancer	0.000414	0.00228	CcSEcCtD
Thiothixene—Rash—Dactinomycin—skin cancer	0.00041	0.00226	CcSEcCtD
Thiothixene—Diarrhoea—Temozolomide—skin cancer	0.000403	0.00222	CcSEcCtD
Thiothixene—Hypersensitivity—Fluorouracil—skin cancer	0.000399	0.0022	CcSEcCtD
Thiothixene—Dry mouth—Docetaxel—skin cancer	0.000399	0.0022	CcSEcCtD
Thiothixene—Anaphylactic shock—Docetaxel—skin cancer	0.000391	0.00216	CcSEcCtD
Thiothixene—Dizziness—Temozolomide—skin cancer	0.000389	0.00214	CcSEcCtD
Thiothixene—Nausea—Dactinomycin—skin cancer	0.000386	0.00213	CcSEcCtD
Thiothixene—Shock—Docetaxel—skin cancer	0.000385	0.00212	CcSEcCtD
Thiothixene—Pruritus—Fluorouracil—skin cancer	0.000384	0.00211	CcSEcCtD
Thiothixene—Thrombocytopenia—Docetaxel—skin cancer	0.000383	0.00211	CcSEcCtD
Thiothixene—Tachycardia—Docetaxel—skin cancer	0.000382	0.0021	CcSEcCtD
Thiothixene—Vomiting—Temozolomide—skin cancer	0.000374	0.00206	CcSEcCtD
Thiothixene—Anorexia—Docetaxel—skin cancer	0.000373	0.00206	CcSEcCtD
Thiothixene—HRH1—head—skin cancer	0.000373	0.0108	CbGeAlD
Thiothixene—HTR2A—female reproductive system—skin cancer	0.000373	0.0108	CbGeAlD
Thiothixene—Rash—Temozolomide—skin cancer	0.000371	0.00204	CcSEcCtD
Thiothixene—Diarrhoea—Fluorouracil—skin cancer	0.000371	0.00204	CcSEcCtD
Thiothixene—Dermatitis—Temozolomide—skin cancer	0.000371	0.00204	CcSEcCtD
Thiothixene—ADRA2A—head—skin cancer	0.000366	0.0106	CbGeAlD
Thiothixene—Hypotension—Docetaxel—skin cancer	0.000366	0.00202	CcSEcCtD
Thiothixene—Dizziness—Fluorouracil—skin cancer	0.000358	0.00198	CcSEcCtD
Thiothixene—Insomnia—Docetaxel—skin cancer	0.000354	0.00195	CcSEcCtD
Thiothixene—Nausea—Temozolomide—skin cancer	0.000349	0.00193	CcSEcCtD
Thiothixene—Dyspnoea—Docetaxel—skin cancer	0.000349	0.00192	CcSEcCtD
Thiothixene—Somnolence—Docetaxel—skin cancer	0.000348	0.00192	CcSEcCtD
Thiothixene—Vomiting—Fluorouracil—skin cancer	0.000345	0.0019	CcSEcCtD
Thiothixene—Rash—Fluorouracil—skin cancer	0.000342	0.00188	CcSEcCtD
Thiothixene—Dermatitis—Fluorouracil—skin cancer	0.000341	0.00188	CcSEcCtD
Thiothixene—Decreased appetite—Docetaxel—skin cancer	0.00034	0.00187	CcSEcCtD
Thiothixene—CYP2D6—female reproductive system—skin cancer	0.000339	0.00986	CbGeAlD
Thiothixene—Fatigue—Docetaxel—skin cancer	0.000337	0.00186	CcSEcCtD
Thiothixene—Constipation—Docetaxel—skin cancer	0.000335	0.00184	CcSEcCtD
Thiothixene—Nausea—Fluorouracil—skin cancer	0.000322	0.00177	CcSEcCtD
Thiothixene—HTR2A—head—skin cancer	0.000311	0.00905	CbGeAlD
Thiothixene—Hypersensitivity—Docetaxel—skin cancer	0.000288	0.00159	CcSEcCtD
Thiothixene—CYP2D6—head—skin cancer	0.000284	0.00824	CbGeAlD
Thiothixene—Asthenia—Docetaxel—skin cancer	0.000281	0.00155	CcSEcCtD
Thiothixene—Pruritus—Docetaxel—skin cancer	0.000277	0.00153	CcSEcCtD
Thiothixene—Diarrhoea—Docetaxel—skin cancer	0.000268	0.00148	CcSEcCtD
Thiothixene—HRH1—lymph node—skin cancer	0.000261	0.00758	CbGeAlD
Thiothixene—Dizziness—Docetaxel—skin cancer	0.000259	0.00143	CcSEcCtD
Thiothixene—ADRA2A—lymph node—skin cancer	0.000256	0.00745	CbGeAlD
Thiothixene—Vomiting—Docetaxel—skin cancer	0.000249	0.00137	CcSEcCtD
Thiothixene—Rash—Docetaxel—skin cancer	0.000247	0.00136	CcSEcCtD
Thiothixene—Dermatitis—Docetaxel—skin cancer	0.000246	0.00136	CcSEcCtD
Thiothixene—Nausea—Docetaxel—skin cancer	0.000232	0.00128	CcSEcCtD
